Jerry Ingram | Authors

R-CHOP is standard of care for advanced DLBCL patients

November 01, 2007

Rituximab (Rituxan) plus CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) is the standard induction therapy for patients with advanced-stage diffuse large B-cell lymphoma, including both elderly and younger patients.

Preop MRI for breast cancer: Intuition no substitute for data

November 01, 2007

For clinicians, MRI may offer a more in-depth view than mammography for planning surgery and screening for contralateral breast cancers, but does use of MRI actually benefit patients?